Cancer World Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
NEWSLETTER  |  PRINT VERSION
Facebook
Twitter
LinkedIn
Cancer World Magazine
Cancer World Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancer World Magazine > News > Non-cancer drugs repurposing, a new trick to win the onco-challenge?
  • News

Non-cancer drugs repurposing, a new trick to win the onco-challenge?

  • 3 February 2020
  • Cristina Ferrario
Non-cancer drugs repurposing, a new trick to win the onco-challenge?
Total
0
Shares
0
0
0
0
0
Originally developed and approved for use in diabetes, inflammation and other non-oncological diseases (even osteoarthritis in dogs), many drugs could have a pivotal role in treating cancer. And they could be more abundant than expected, according to a paper recently published in Nature Cancer. “Anticancer uses of non-oncology drugs have occasionally been found, but such discoveries have been serendipitous” wrote the authors, led by Steven Corsello, medical oncologist at the Dana-Farber Cancer Institute (Boston). Corsello is the founder of the Drug Repurposing Hub at the Broad Institute of MIT and Harvard, an information resource providing extensive annotations for thousands of drugs. He and colleagues systematically tested 4,518 drug compounds from the above-mentioned Drug Repurposing Hub across 578 human cancer cell lines, evaluating their effects on cell viability. For this screening, researchers used a molecular barcoding method called PRISM (profiling relative inhibition simultaneously in mixtures), recovering almost 50 non-oncology compounds with previously unknown selective anticancer activity, predictable by the molecular characteristics of the cell line. Interestingly, the analysis also revealed new targets and molecular mechanisms of action, paving the way to the development of new anticancer drugs. Moving from experimental to clinical settings, authors reminded that the ability to kill cancer cells shown by some non-oncology compounds does not mean that they could be immediately tested in cancer patients. “The PRISM results reported in this study represent starting points for new drug development. When the anticancer activity of a drug occurs via an off-target mechanism, it is probable that further optimization for this new target will result in more potent and selective drug candidates” experts explained. “Further development of such compounds as repurposed cancer drugs will probably require extensive chemical and pharmacological optimization and validation, but this unbiased multi-platform approach does provide a unique starting point for future efforts” confirmed Roderick L. Beijersbergen, NKI Robotics and Screening Center, The Netherlands Cancer Institute, Amsterdam in a commentary.
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • drug repurposing
  • hub
  • repurposing
Avatar
Cristina Ferrario

Previous Article
  • News

Genetics of breast cancer: much more than a BRCA story

  • 27 January 2020
  • Elena Riboldi
View Post
Next Article
  • Editorials

Tackling cancer in interesting times

  • 4 February 2020
  • Adriana Albini
View Post
You May Also Like
View Post
  • News

Study brings mass biparametric MRI screening for prostate cancer a step closer

  • Janet Fricker
  • 23 February 2021
View Post
  • News

Oncology providers urged to offer healthy life style advice to breast cancer survivors

  • Janet Fricker
  • 19 February 2021
View Post
  • News

Studies provide clarity on breast cancer genes for genetic panels

  • Janet Fricker
  • 9 February 2021
View Post
  • News

EC publishes route map for tackling cancer

  • Janet Fricker
  • 5 February 2021
View Post
  • News

Therapy targeting androgen receptors opens new chapter for hormone driven breast cancers

  • Janet Fricker
  • 27 January 2021
View Post
  • News

Coffee may protect against prostate cancer

  • Janet Fricker
  • 20 January 2021
View Post
  • News

Financial burden on older adults with advanced cancer worsens quality of life

  • Janet Fricker
  • 15 January 2021
View Post
  • News

Integrated imaging opens the way for virtual biopsies

  • Janet Fricker
  • 15 January 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancer World archive
Latest news
  • Study brings mass biparametric MRI screening for prostate cancer a step closer
    • 23 February 2021
  • Oncology providers urged to offer healthy life style advice to breast cancer survivors
    • 19 February 2021
  • Studies provide clarity on breast cancer genes for genetic panels
    • 9 February 2021
  • EC publishes route map for tackling cancer
    • 5 February 2021
  • Therapy targeting androgen receptors opens new chapter for hormone driven breast cancers
    • 27 January 2021
Latest printed issue
Article
  • Immunotherapy toxicities demand a joined up approach from oncologists and organ specialists
    • 24 February 2021
  • Beating cancer is complex – our messaging must be clear
    • 11 February 2021
  • Who wouldn’t want to cure 100% of childhood cancers?
    • 29 January 2021
Newsletter

Don't miss our newsletter

Would you like to receive our bimonthly e-newsletter with the latest news from Cancer World magazine?

Subscribe now
Social

Would you follow us ?

Contents
  • Moving towards efficiency in cancer care: Examples
    • 8 February 2021
  • World Cancer Day: we commemorate Professor Agim Sallaku
    • 3 February 2021
  • Gordon McVie 1945–2021: a lifetime dedicated to defeating cancer
    • 22 January 2021
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancer World Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancer World is managed by SPCC Sharing Progress in Cancer Care | Piazza Indipendenza 2, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.